Search

Your search keyword '"Drug resistance in microorganisms -- Drug therapy"' showing total 1,131 results
Start Over Descriptor "Drug resistance in microorganisms -- Drug therapy"
1,131 results on '"Drug resistance in microorganisms -- Drug therapy"'

51. Could OTC Nasal Sprays Ease Colds & Flu and Cut Antibiotic Use?

Subjects
Nonprescription drugs -- Health aspects, Drug resistance in microorganisms -- Drug therapy, Bacterial infections -- Drug therapy, Influenza -- Drug therapy -- Control, Intranasal medication -- Health aspects, Antibiotics -- Health aspects, Health
Abstract

Byline: Carole Tanzer Miller HealthDay Reporter MONDAY, July 15, 2024 (HealthDay News) -- Over-the-counter nasal sprays could be a potent weapon against a major public health threat -- antibiotic resistance, [...]

Published
2024

52. PEOPLE'S HOSPITAL OF CHUXIONG YI AUTONOMOUS PREFECTURE invites tenders for Multi-Drug-Resistant Tuberculosis Rapid Molecular Detector and Flow Cytometer

Subjects
Antitubercular agents, Drug resistance in microorganisms -- Drug therapy, Detectors, Tuberculosis -- Drug therapy, News, opinion and commentary
Abstract

PEOPLE'S HOSPITAL OF CHUXIONG YI AUTONOMOUS PREFECTURE, China has invited tenders for Multi-Drug-Resistant Tuberculosis Rapid Molecular Detector and Flow Cytometer. Tender Notice No: CXZC2024-G1-00186-CXWH-0003 Deadline: June 12, 2024 Copyright © [...]

Published
2024

53. Asia-Pacific gets new weapon in fight against drug-resistant T

Subjects
Patient compliance, Drugs -- Prescribing, Drug resistance in microorganisms -- Drug therapy, Tuberculosis -- Drug therapy, Business, General interest, Business, international, News, opinion and commentary
Abstract

MANILA, April 12 -- A faster and vastly more effective treatment for drug-resistant tuberculosis is being rolled out in the Asia-Pacific region, raising hopes of a 'new era' in tackling [...]

Published
2024

54. Researchers at University of Science and Technology China Report New Data on Fullerenes (Edge-selective Covalent Passivation of Black Phosphorus Nanosheets By Fullerene C70 Toward Enhanced Antimicrobial Performance)

Subjects
Infection control, Drug resistance in microorganisms -- Drug therapy, Bacterial infections -- Drug therapy, Methicillin, Antibiotics, Physical fitness, Health
Abstract

2023 DEC 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Nanotechnology - Fullerenes. According to news reporting [...]

Published
2023

55. Reports Outline Cancer Study Results from Sichuan University (Nanodelivery Systems As a Novel Strategy To Overcome Treatment Failure of Cancer)

Subjects
Oncology, Experimental, Drug resistance in microorganisms -- Drug therapy, Cancer -- Drug therapy -- Research, Physical fitness, Health
Abstract

2023 DEC 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Cancer. According to news reporting out of [...]

Published
2023

56. Researchers at China Three Gorges University Release New Data on Cancer [Recent Advances On Pyrazole-pyrimidine/fused Pyrimidine Hybrids With Anticancer Potential (A Review)]

Subjects
Oncology, Experimental, Drug resistance in microorganisms -- Drug therapy, Pyrimidines, Cancer -- Drug therapy -- Research, Physical fitness, Health
Abstract

2023 NOV 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Cancer. According to news reporting originating from [...]

Published
2023

57. Reports from Laboratory of Immunotherapy Advance Knowledge in Breast Cancer (MDR1-EXPRESSING CD4[superscript]+T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSE)

Subjects
Women -- Health aspects, T cells, Cancer -- Adjuvant treatment, Drug resistance in microorganisms -- Drug therapy, Immunotherapy, Breast cancer -- Drug therapy, Health, Women's issues/gender studies
Abstract

2023 NOV 23 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A new study on breast cancer is now available. According to news reporting originating [...]

Published
2023

58. Data from Deraya University Advance Knowledge in Gram-Negative Bacteria (Comparative Investigation into the Roles of Imipenem:Cyclodextrin Complexation and Antibiotic Combination in Combatting Antimicrobial Resistance in Gram-Negative Bacteria)

Subjects
Drug resistance in microorganisms -- Drug therapy, Imipenem -- Comparative analysis -- Investigations, Gram-negative bacteria -- Investigations -- Comparative analysis, Physical fitness -- Investigations -- Comparative analysis, Company legal issue, Health
Abstract

2023 NOV 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on gram-negative bacteria. According to news reporting out [...]

Published
2023

59. Allama Iqbal Medical College Researchers Have Provided New Study Findings on Antibiotics (Proton pump inhibitors- Adversaries in our fight against antibiotic resistance?)

Subjects
Adenosine triphosphatase, Drug resistance in microorganisms -- Drug therapy, Gastroesophageal reflux -- Drug therapy, Proton pump inhibitors, Physical fitness, Health
Abstract

2023 NOV 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in antibiotics. According to news reporting originating from [...]

Published
2023

60. Research on Acute Pyelonephritis Described by a Researcher at Department of Pharmacy (Application of Precision Medicine Concepts in Ambulatory Antibiotic Management of Acute Pyelonephritis)

Subjects
Urinary tract infections -- Drug therapy, Women -- Health aspects, Pyelonephritis -- Drug therapy, Drug resistance in microorganisms -- Drug therapy, Pharmacy, Antibiotics, Health, Women's issues/gender studies
Abstract

2023 NOV 16 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on acute pyelonephritis. According to news originating from Columbia, South [...]

Published
2023

61. The anticancer chemotherapy drug 5-Fluorouracil has positive interaction with antibiotics and can select for antibiotic resistance in Staphylococcus aureus

Subjects
Staphylococcus aureus, Drug resistance in microorganisms -- Drug therapy, Fluorouracil, Chemotherapy, Drug interactions, Cancer -- Chemotherapy, Physical fitness, Health
Abstract

2023 OCT 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]

Published
2023

62. Findings from West Kazakhstan Marat Ospanov Medical University in Pneumonia Reported [Bibliometric Analysis of Global Research Output on Antimicrobial Resistance among Pneumonia Pathogens (2013-2023)]

Subjects
Bacterial pneumonia -- Drug therapy, Drug resistance in microorganisms -- Drug therapy, Pneumonia -- Drug therapy, Physical fitness -- Analysis, Pathogenic microorganisms -- Analysis, Health
Abstract

2023 OCT 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on pneumonia have been presented. According to news reporting out [...]

Published
2023

63. Study Data from Institute of Bio- und Geosciences Update Knowledge of Bacterial Infections and Mycoses (Resistance against aminoglycoside antibiotics via drug or target modification enables community-wide antiphage defense)

Subjects
Medical research, Medicine, Experimental, Drug resistance in microorganisms -- Drug therapy, Bacterial infections -- Drug therapy, Infection -- Drug therapy, Aminoglycosides, Health
Abstract

2024 SEP 6 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Research findings on bacterial infections and mycoses are discussed in a new report. [...]

Published
2024

64. Study Findings on HIV/AIDS Discussed by a Researcher at Augusta University (Enhancing Precision in HIV Treatment: Validation of a Robust Next-Generation Sequencing System for Drug Resistance Mutation Analysis)

Subjects
HIV (Viruses) -- Drug therapy, Drug resistance in microorganisms -- Drug therapy, Highly active antiretroviral therapy -- Reports, AIDS treatment -- Reports, Health
Abstract

2024 SEP 2 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Fresh data on HIV/AIDS are presented in a new report. According to news reporting originating [...]

Published
2024

65. Researchers from Harvard Medical School Report Details of New Studies and Findings in the Area of Multidrug Resistant Tuberculosis (Safety and Effectiveness of 3 Novel All-oral Shortened Regimens for Rifampicin- or Multidrug-resistant ...)

Subjects
Management science, Drug resistance in microorganisms -- Drug therapy, Rifampin, Tuberculosis -- Drug therapy, Health, Harvard University. Harvard Medical School
Abstract

2024 AUG 20 (NewsRx) -- By a News Reporter-Staff News Editor at TB & Outbreaks Week -- Researchers detail new data in Drugs and Therapies - Multidrug Resistant Tuberculosis. According [...]

Published
2024

66. Reports from Immunology and Infectious Diseases Advance Knowledge in Bacterial Infections and Mycoses (Biogenic silver nanomaterials synthesized from Ocimum sanctum leaf extract exhibiting robust antimicrobial and anticancer activities: ...)

Subjects
Medical research, Medicine, Experimental, Silver -- Exhibitions, Drug resistance in microorganisms -- Drug therapy, Medicine, Botanic, Bacterial infections -- Drug therapy, Cancer -- Care and treatment, Infection -- Drug therapy, Medicine, Herbal, Biological sciences, Health
Abstract

2024 AUG 20 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- Researchers detail new data in bacterial infections and mycoses. According to news reporting originating [...]

Published
2024

67. Investigators from Kerman University of Medical Sciences Target Tuberculosis (Fecal Microbiota Transplantation: a Potential Novel Treatment Strategy for Extensively Drug-resistant Tuberculosis)

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Microbiota (Symbiotic organisms) -- Health aspects, Patient compliance -- Health aspects, Antitubercular agents -- Health aspects, Drug resistance in microorganisms -- Drug therapy, Tuberculosis -- Drug therapy, Health, Drug therapy, Health aspects
Abstract

2024 AUG 6 (NewsRx) -- By a News Reporter-Staff News Editor at TB & Outbreaks Week -- Investigators discuss new findings in Mycobacterium Infections - Tuberculosis. According to news reporting [...]

Published
2024

68. Findings on Respiratory Tract Infections Discussed by Investigators at Catalan Institute of Health (Optimising Antibiotic Exposure By Customising the Duration of Treatment for Respiratory Tract Infections Based On Patient Needs In Primary Care)

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Respiratory tract diseases -- Drug therapy, Drug resistance in microorganisms -- Drug therapy, Infection -- Drug therapy, Antibiotics -- Health aspects, Health, Drug therapy, Health aspects
Abstract

2024 AUG 5 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Data detailed on Respiratory Tract Diseases and Conditions - Respiratory Tract Infections have been [...]

Published
2024

69. Fifth Affiliated Hospital of Xinjiang Medical University Researchers Have Provided New Study Findings on Pseudomonas aeruginosa (Characterization of the novel broad-spectrum lytic phage Phage_Pae01 and its antibiofilm efficacy against ...)

Subjects
Drug resistance in microorganisms -- Drug therapy, Antibiotics, Pseudomonas aeruginosa, Health
Abstract

2024 AUG 2 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Research findings on Pseudomonas aeruginosa are discussed in a new report. According to [...]

Published
2024

70. Data from National Engineering Research Center of Genetic Medicine Provide New Insights into Bacterial Infections and Mycoses (Adenosine Monophosphate as a Metabolic Adjuvant Enhances Antibiotic Efficacy against Drug-Resistant Bacterial ...)

Subjects
Medical research, Medicine, Experimental, Adenylic acid, Adenosine, Engineering research, Drug resistance in microorganisms -- Drug therapy, Bacterial infections -- Drug therapy, Infection -- Drug therapy, Genetic engineering, Health
Abstract

2024 AUG 2 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on bacterial infections and mycoses is now available. According to [...]

Published
2024

73. Transmission is a key driver of extensively drug-resistant tuberculosis

Subjects
Drug resistance in microorganisms -- Drug therapy, Drugs, Tuberculosis -- Drug therapy, Epidemiology, Health
Abstract

2024 JUL 16 (NewsRx) -- By a News Reporter-Staff News Editor at TB & Outbreaks Week -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2024

74. New HIV/AIDS Study Findings Have Been Reported by Investigators at East Tennessee State University (Consensus Recommendations for the Use of Novel Antiretrovirals In Persons With Hiv Who Are Heavily Treatment-experienced And/or Have ...)

Subjects
United States. Food and Drug Administration -- Reports, HIV (Viruses) -- Drug therapy, Drug resistance in microorganisms -- Drug therapy, HIV patients -- Drug therapy, Health, Tennessee State University -- Reports
Abstract

2024 JUL 8 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Investigators publish new report on Immune System Diseases and Conditions - HIV/AIDS. According to news [...]

Published
2024

75. Investigators from Harvard Medical School Release New Data on Mycobacterium tuberculosis (Drug Resistance and Epidemiological Success of Modern mycobacterium Tuberculosis lineages In Western India)

Subjects
United States. National Institutes of Health, Antitubercular agents, Drug resistance in microorganisms -- Drug therapy, Tuberculosis -- Drug therapy, Epidemiology, Health, Harvard University. Harvard Medical School
Abstract

2024 JUL 8 (NewsRx) -- By a News Reporter-Staff News Editor at Tuberculosis Week -- Fresh data on Gram-Positive Bacteria - Mycobacterium tuberculosis are presented in a new report. According [...]

Published
2024

76. Vibrio cholerae O1 associated with recent endemic cholera shows temporal changes in serotype, genotype, and drug-resistance patterns in Bangladesh

Author

Jubyda, Fatema Tuz, Nahar, Kazi Sumaita, Barman, Indrajeet, Johura, Fatema-Tuz, Islam, Mohammad Tarequl, Sultana, Marzia, Ullah, Wali, Tasnim, Jarin, Biswas, Sahitya Ranjan, Monir, Md Mamun, George, Christine Marie, Camilli, Andrew, Ahmed, Niyaz, Ross, Allen G., Clemens, John D., and Alam, Munirul

Subjects
Cholera toxin -- Analysis, Beta lactamases -- Analysis, Drug resistance in microorganisms -- Drug therapy, Cholera -- Drug therapy, Health
Abstract

Background Despite the advancement in our understanding of cholera and its etiological agent, Vibrio cholerae, the prevention and treatment of the disease are often hindered due to rapid changes in drug response pattern, serotype, and the major genomic islands namely, the CTX-prophage, and related genetic characteristics. In the present study, V. cholerae (n = 172) associated with endemic cholera in Dhaka during the years 2015-2021 were analyzed for major phenotypic and genetic characteristics, including drug resistance patterns. Results Results revealed that the V. cholerae strains belonged to serogroup O1 biotype El Tor carrying El Tor -specific genes rtxC, tcpA El Tor, and hlyA El Tor, but possessed classical-biotype cholera toxin. Serotypes of V. cholerae strains differed temporally in predominance with Inaba during 2015-2017, and again in 2020-2021, while Ogawa was the predominant serotype in 2018-2019. Also, ctxB1 was predominant in V. cholerae associated with cholera during 2015-2017, while ctxB7 was predominant in 2018, and in the subsequent years, as observed until 2021. V. cholerae strains differed in their antibiotic resistance pattern with a majority (97%) being multi-drug resistant (MDR) and belonging to six sub-groups. Notably, one of these MDR strains was resistant to eleven of the eighteen antibiotics tested, with resistance to fourth-generation cephalosporin (cefepime), and aztreonam. This extreme drug resistant (XDR) strain carried resistance-related genes namely, extended-spectrum [beta]-lactamases (ESBL), blaOXA-1 and blaPER-3. Conclusion The observed temporal switching of serotypes, as well as the ctxB genotype, and the emergence of MDR/XDR V. cholerae and their association with endemic cholera in Dhaka underscore the need for routine monitoring of the pathogen for proper patient management. Keywords: Vibrio cholerae, Temporal transition, Multi-drug resistant, Author(s): Fatema Tuz Jubyda[sup.1,2], Kazi Sumaita Nahar[sup.1], Indrajeet Barman[sup.1], Fatema-Tuz Johura[sup.1], Mohammad Tarequl Islam[sup.1], Marzia Sultana[sup.1], Wali Ullah[sup.1], Jarin Tasnim[sup.1], Sahitya Ranjan Biswas[sup.1], Md Mamun Monir[sup.1], Christine Marie George[sup.3], Andrew [...]

Published
2023
Full Text
View/download PDF

77. Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria

Subjects
Eli Lilly and Co., Bacteria, Drug resistance in microorganisms -- Drug therapy, Pharmaceutical industry, Business, News, opinion and commentary
Abstract

INDIANAPOLIS, June 25, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced a collaboration with OpenAI that will allow Lilly to leverage OpenAI's generative AI to invent novel antimicrobials [...]

Published
2024

78. Tajikistan : A timeline of tuberculosis treatment success in Tajikistan

Subjects
Drug resistance in microorganisms -- Drug therapy, Tuberculosis -- Drug therapy, Patient education -- Chronologies, Business, international
Abstract

After 13 years of collaboration with the Ministry of Health and Social Protection of Population, Mdecins Sans Frontires (MSF) has concluded our tuberculosis (TB) project in Dushanbe, Tajikistan. MSFs work [...]

Published
2024

79. United Kingdom : VDEC develops a tool to reduce antimicrobial resistance to tuberculosis

Subjects
Drug resistance in microorganisms -- Drug therapy, Tuberculosis -- Drug therapy, Chemotherapy, Vaccines, Cancer -- Chemotherapy, Business, international
Abstract

The Vaccine Development and Evaluation Centre (VDEC) has developed a standardised assay as a tool to screen compound libraries against Mycobacterium tuberculosis in conjunction with a commonly used chemotherapy drug, [...]

Published
2024

80. United Kingdom : VDEC develops a tool to reduce antimicrobial resistance to tuberculosis

Subjects
Drug resistance in microorganisms -- Drug therapy, Tuberculosis -- Drug therapy, Chemotherapy, Vaccines, Cancer -- Chemotherapy, Business, international
Abstract

The Vaccine Development and Evaluation Centre (VDEC) has developed a standardised assay as a tool to screen compound libraries against Mycobacterium tuberculosis in conjunction with a commonly used chemotherapy drug, [...]

Published
2024

81. EU Contract Notice: Malopolski Szpital Chorob Pluc i Rehabilitacji im. Edmunda Wojtyly Issues contract notice|solicitation for 'Successful delivery of drugs used in the treatment of drug-resistant tuberculosis'

Subjects
Drug resistance in microorganisms -- Drug therapy, Drugs, Tuberculosis -- Drug therapy, Contract agreement, Business, international
Abstract

Luxembourg: Malopolski Szpital Chorob Pluc i Rehabilitacji im. Edmunda Wojtyly has issued contract notice/solicitation for 'Successful delivery of drugs used in the treatment of drug-resistant tuberculosis' Reference no: 316351-2024 Posted [...]

Published
2024

82. Visby Medical(TM) Sexual Health Test Results in More Appropriate Antibiotic Treatment and Shorter Emergency Department Visits Than Standard of Care

Subjects
Sexually transmitted diseases -- Drug therapy, Hospitals -- Emergency service, Drug resistance in microorganisms -- Drug therapy, Disease transmission, Antibiotics -- Standards, Business, News, opinion and commentary
Abstract

Point-of-Care test significantly shortens time from ED arrival to test results, treatment and discharge -- significant improvements are seen in the use of antibiotics for the treatment of chlamydia and [...]

Published
2024

83. Peru : Minsa and TB Alliance strengthen progress in the implementation of short-term treatments for drug-resistant tuberculosis in Peru

Subjects
Drug resistance in microorganisms -- Drug therapy, Drugs, Tuberculosis -- Drug therapy, Cabinet officers, Business, international
Abstract

The Ministry of Health (Minsa) continues to strengthen the fight against tuberculosis. The Deputy Minister of Public Health, Ricardo Pea Snchez, on behalf of the Minister of Health, Csar Vsquez [...]

Published
2024

84. United Kingdom : VDEC develops a tool to reduce antimicrobial resistance to tuberculosis

Subjects
Drug resistance in microorganisms -- Drug therapy, Tuberculosis -- Drug therapy, Chemotherapy, Vaccines, Cancer -- Chemotherapy, Business, international
Abstract

The Vaccine Development and Evaluation Centre (VDEC) has developed a standardised assay as a tool to screen compound libraries against Mycobacterium tuberculosis in conjunction with a commonly used chemotherapy drug, [...]

Published
2024

85. VDEC develops a tool to reduce antimicrobial resistance to tuberculosis

Subjects
Drug resistance in microorganisms -- Drug therapy, Tuberculosis -- Drug therapy, Chemotherapy, Vaccines, Cancer -- Chemotherapy, Business, international
Abstract

London: UK Government has issued the following news release: VDEC developed a standardised assay reduce the development of antimicrobial resistance and improve patient treatment for tuberculosis. The Vaccine Development and [...]

Published
2024

86. VDEC DEVELOPS A TOOL TO REDUCE ANTIMICROBIAL RESISTANCE TO TUBERCULOSIS

Subjects
Drug resistance in microorganisms -- Drug therapy, Tuberculosis -- Drug therapy, Chemotherapy, Vaccines, Cancer -- Chemotherapy, News, opinion and commentary
Abstract

LONDON -- The following information was released by the UK Government: VDEC developed a standardised assay reduce the development of antimicrobial resistance and improve patient treatment for tuberculosis. From: UK [...]

Published
2024

87. GSK to become a founding partner of Fleming Initiative to fight antimicrobial resistance (AMR) | GSK

Subjects
Communicable diseases -- Drug therapy, Drug resistance in microorganisms -- Drug therapy, Methicillin -- Health aspects, Public health -- Health aspects, Business, Business, international
Abstract

M2 PRESSWIRE-May 16, 2024-: GSK to become a founding partner of Fleming Initiative to fight antimicrobial resistance (AMR) | GSK (C)1994-2024 M2 COMMUNICATIONS RDATE:15052024 *Company makes [pounds sterling]45m pledge to [...]

Published
2024

89. Paragon Novel Vaccine (PNV) an effective protection against all serotypes of five deadly bacteria to eradicate Antimicrobial Resistance (AMR)

Subjects
Bacteria, Drug resistance in microorganisms -- Drug therapy, Immunotherapy, Bacterial infections -- Drug therapy, Antibacterial agents -- Contamination, Vaccines -- Contamination, Business, international, European Union
Abstract

Paragon Novel Vaccine (Pnv) An Effective Protection Against All Serotypes Of Five Deadly Bacteria To Eradicate Antimicrobial Resistance (Amr) Multipotent Antibacterial Vaccineantibiotic Resistance Is An Emerging Medical Problem Of Global [...]

Published
2024

90. Drugs that aren’t antibiotics can also kill bacteria − new method pinpoints how

Author

Guillen, Mariana Noto

Subjects
Bacteria -- Analysis -- Methods, Drug resistance in microorganisms -- Drug therapy, Antibacterial agents -- Methods -- Analysis, News, opinion and commentary
Abstract

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) https://theconversation.com/profiles/mariana-noto-guillen-1521612, https://theconversation.com/institutions/umass-chan-medical-school-2215 (THE CONVERSATION) Human history was forever changed with the https://theconversation.com/the-rise-and-fall-of-antibiotics-what-would-a-post-antibiotic-world-look-like-213450 in 1928. [...]

Published
2024

91. Switzerland : WHO announces forthcoming updates on co-administration of treatment for drug-resistant tuberculosis and hepatitis C

Subjects
Drug resistance in microorganisms -- Drug therapy, Rifampin, Hepatitis C virus, Tuberculosis -- Drug therapy, Hepatitis C -- Drug therapy, Business, international, World Health Organization
Abstract

In a Rapid Communication issued today, the World Health Organization (WHO) is announcing updates on co-administration of treatment for drug-resistant tuberculosis and hepatitis C (HCV). The evidence suggests that concomitant [...]

Published
2024

92. Antibiotics: Are you misusing them?

Subjects
Bacteria -- Health aspects, Drug resistance in microorganisms -- Drug therapy, Bacterial infections -- Drug therapy, Infection -- Drug therapy, Disease transmission -- Health aspects, Antibiotics -- Health aspects, Health
Abstract

Antibiotics are important drugs. Many antibiotics can successfully treat infections caused by bacteria (bacterial infections). Antibiotics can prevent the spread of disease. And antibiotics can reduce serious disease complications. But [...]

Published
2024

93. CO-ADMINISTRATION OF TREATMENT FOR DRUG-RESISTANT TUBERCULOSIS AND HEPATITIS C: RAPID COMMUNICATION

Subjects
Evidence, Expert, Antitubercular agents, Drug resistance in microorganisms -- Drug therapy, Hepatitis C virus, Tuberculosis -- Drug therapy, Hepatitis C -- Drug therapy, News, opinion and commentary, World Health Organization
Abstract

GENEVA, Switzerland -- The following information was released by the World Health Organization: Overview This rapid communication aims to inform national TB programmes, technical partners, and other stakeholders about the [...]

Published
2024

94. Antibiotics: Are you misusing them?

Subjects
Bacteria -- Health aspects, Drug resistance in microorganisms -- Drug therapy, Bacterial infections -- Drug therapy, Infection -- Drug therapy, Disease transmission -- Health aspects, Antibiotics -- Health aspects, Health
Abstract

Antibiotics are important drugs. Many antibiotics can successfully treat infections caused by bacteria (bacterial infections). Antibiotics can prevent the spread of disease. And antibiotics can reduce serious disease complications. But [...]

Published
2024

98. Reports on Cancer from Jamia Hamdard Provide New Insights (Aptamers Against Cancer Drug Resistance: Small Fighters Switching Tactics In the Face of Defeat)

Subjects
Oncology, Experimental, Drug resistance in microorganisms -- Drug therapy, Chemotherapy, Cancer -- Chemotherapy -- Research, Physical fitness, Health
Abstract

2023 SEP 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Cancer is the subject of a report. According to [...]

Published
2023

99. Innoviva introduces Xacduro, an antibiotic developed to target acinetobacter to treat HABP and ventilator-associated bacterial pneumonia in adults

Subjects
Innoviva Inc. -- Product introduction, Bacterial pneumonia -- Drug therapy, Drug resistance in microorganisms -- Drug therapy, Biotechnology industry -- Product introduction, Sulbactam -- Product introduction, Pneumonia -- Drug therapy, Adults, Pharmaceuticals and cosmetics industries
Abstract

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc., announced that Xacduro (sulbactam for injection; durlobactam for injection) is now available in the United States for patients 18 years of age [...]

Published
2023

100. Studies from Naval Medical University Yield New Information about Breast Cancer (A Ph-responsive Complex Based On Supramolecular Organic Framework for Drug-resistant Breast Cancer Therapy)

Subjects
Oncology, Experimental -- Health aspects -- Reports, Drugs -- Vehicles -- Health aspects -- Reports, Drug resistance in microorganisms -- Drug therapy, Medical colleges -- Health aspects -- Reports, Chemotherapy -- Health aspects -- Reports, Cancer -- Chemotherapy -- Research, Breast cancer -- Drug therapy, Drug delivery systems -- Reports -- Health aspects, Physical fitness -- Health aspects -- Reports, Health
Abstract

2023 SEP 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Oncology - Breast Cancer are discussed in a new [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results